EMAIL THIS PAGE TO A FRIEND

Molecular bioSystems

Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula.


PMID 23348248

Abstract

Traditional Chinese Medicine (TCM) remedies are composed of different chemical compounds. To understand the underlying pharmacological basis, we need to explore the active components, which function systematically against multiple gene targets to exert efficacy. Predicting active component-gene target interactions could help us decipher the mechanism of action of TCM. Here, we introduce a Pathway Pattern-based method to prioritize the 153 candidate compounds and 7895 associated genes using the extracted Pathway Pattern, which is made up of groups of pathways. The gene prioritization result is compared to previous literature findings to demonstrate the top ranked genes' roles in the pathogenesis of H1N1 influenza. Further, molecular docking is utilized to validate compounds' effects through docking compounds into drug targets of oseltamivir. After setting thresholds, 16 active components, 29 gene targets and 162 active component-gene target interactions are finally identified to elucidate the pharmacology of maxingshigan-yinqiaosan formula. This novel strategy is expected to serve as a springboard for the efforts to standardize and modernize TCM.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N7271 α(2→3) Neuraminidase from Streptococcus pneumoniae, buffered aqueous solution
N5521 α(2→3,6) Neuraminidase from Clostridium perfringens (C. welchii), recombinant, expressed in E. coli, buffered aqueous solution, ≥250 units/mg protein
N3786
α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens, Proteomics Grade, suitable for MALDI-TOF MS
N8271 α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens, recombinant, expressed in E. coli, buffered aqueous solution
E0287 Carboxylesterase 1 isoform b human, recombinant, expressed in baculovirus infected BTI insect cells
E0162 Carboxylesterase 1 isoform c human, recombinant, expressed in baculovirus infected BTI insect cells
C4749 Carboxylesterase 2 human, recombinant, expressed in mouse NSO cells, ≥95% (SDS-PAGE)
46051 Esterase from Bacillus stearothermophilus, ≥0.2 U/mg
79302 Esterase from Bacillus stearothermophilus, recombinant, expressed in E. coli, ≥8.0 U/mg
96667 Esterase from Bacillus subtilis, recombinant, expressed in E. coli, ≥10 U/mg
51963 Esterase from Bacillus subtilis, recombinant, expressed in E. coli, ≥0.8 U/mg
46069 Esterase from horse liver, lyophilized, powder, brown, 0.5-1.0 U/mg
46058 Esterase from porcine liver, lyophilized, powder, slightly beige, ≥50 U/mg
E0887 Esterase from rabbit liver, lyophilized powder, ≥75 units/mg protein
79208 Esterase from Rhizopus oryzae, powder, light beige, ≥20 U/g
46071 Esterase from Saccharomyces cerevisiae, lyophilized, powder, beige, ~2 U/g
43388 Esterase Isoenzyme 1 porcine liver, recombinant, recombinant, expressed in E. coli, ≥30.0 U/g
93855 Esterase Isoenzyme 2 porcine liver, recombinant, recombinant, expressed in E. coli, ≥80 U/g
93712 Esterase Isoenzyme 3 porcine liver, recombinant, recombinant, expressed in E. coli, ≥0.8 U/mg
68998 Esterase Isoenzyme 4 porcine liver, recombinant, recombinant, expressed in E. coli, ≥0.7 U/mg
53564 Esterase Isoenzyme 5 porcine liver, recombinant, recombinant, expressed in E. coli, ≥0.5 U/mg
80712 Esterase Methylobacterium populi, recombinant, recombinant, expressed in E. coli, ≥0.5 U/mg
92385 Esterase Nocardia farcinica, recombinant, recombinant, expressed in E. coli, ≥0.4 U/mg
04492 Esterase Paenibacillus barcinonensis, recombinant, recombinant, expressed in E. coli, ≥12 U/mg
04533 Esterase Pelobacter propionicus, recombinant, recombinant, expressed in E. coli, ≥0.5 U/mg
75742 Esterase Pseudomonas fluorescens, recombinant from E. coli, ≥4 U/mg
80711 Esterase Pseudomonas fluorescens, recombinant from E. coli, ≥0.3 U/mg
62350 Lipozyme®, immobilized from Mucor miehei, granular, brown, >30 U/g
N5254 Neuraminidase Agarose from Clostridium perfringens (C. welchii), Type VI-A, ammonium sulfate suspension
N2133
Neuraminidase from Clostridium perfringens (C. welchii), Type X, lyophilized powder, ≥50 units/mg protein (using 4MU-NANA)